Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03123263 · ClinicalTrials.gov registry record
Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer
A clinical trial, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- 60
- Enrollment target
NCT03123263 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 60 participants.
The verdict
NCT03123263 has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study retrospectively looks at changes in Echocardiographic parameters while using transtuzumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2019-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03123263
The ClinicalTrials.gov registry entry for NCT03123263 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03123263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03123263 about?
NCT03123263 is a clinical study titled "Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer". This study retrospectively looks at changes in Echocardiographic parameters while using transtuzumab
What is the current status of trial NCT03123263?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2017-04-11. Estimated completion is 2019-02-26.
Who is sponsoring clinical trial NCT03123263?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.